Boston Scientific Corporation (BSX)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Boston Scientific Corporation (BSX) is down 53.5% since the beginning of the year. At $44 per share, BSX is trading 59.5% below its 52-week high of $110. Investors who bought $1,000 worth of BSX shares 5 years ago would now be looking at an investment worth $1,013.

Boston Scientific Corporation (BSX) has returned -53.51% so far this year and -56.24% over the past 12 months. Over the last ten years, BSX has returned 7.08% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.

Based on dividend-adjusted daily data since May 19, 1992, BSX's average daily return is +0.06%, while the average monthly return is +1.07%. At this rate, an investment would double in approximately 5.4 years.

Historically, 55% of months were positive and 45% were negative. The best month was Mar 1999 with a return of +53.3%, while the worst month was Nov 2008 at -31.7%. The longest winning streak lasted 10 consecutive months, and the longest losing streak was 8 months.

On a daily basis, BSX closed higher 49% of trading days. The best single day was Oct 13, 2008 with a return of +26.1%, while the worst single day was Jul 19, 2000 at -26.7%.

Boston Scientific Corporation has an annualized alpha of 5.00%, beta of 0.91, and R2 of 0.19 versus S&P 500 Index. Calculated based on daily prices since May 19, 1992.

• This stock participated in 108.22% of S&P 500 Index downside but only 100.37% of its upside - more exposed to losses than it benefited from rallies.
• R2 of 0.19 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

BSX ranks 1 for risk / return — in the bottom 1% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Boston Scientific Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Boston Scientific Corporation was 89.15%, occurring on Jul 26, 2012. Recovery took 2268 trading sessions.

The current Boston Scientific Corporation drawdown is 59.01%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Boston Scientific Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Boston Scientific Corporation is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.